Skip to main content
. 2022 Mar 1;12:846232. doi: 10.3389/fonc.2022.846232

Figure 3.

Figure 3

Genomic landscape of meningiomas included in the cohort. (A) Depiction of all Grade 1 meningioma cases harboring high grade (red) or low grade (green) copy number profiles and sequence alterations as determined by advanced molecular profiling. (B) Plot showing copy number alterations and sequence alteration for all WHO grade 2 and 3 cases included in the study. For both (A, B) each vertical column represents one case. TERT mutations were in the promoter in 17% (1 case) of WHO Grade 1 meningiomas (A) and in all of the WHO grade 2 TERT mutated meningiomas (1 case) (B).